Novartis India share news and announcements
NSE: NOVARTINDBSE: 500672Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,684.50.
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,505 Cr1,055th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 46.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,46,21823.7% delivered
Novartis India share news and announcements
606 announcements, routine notices left out, newest first. Page 6 of 13.
Aug 2021
11 Aug · Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On Wednesday, August 11, 2021
Jul 2021
20 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....15 Jul · Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021
15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
30 Jun · Board meeting
Meeting on 11 Aug 2021: quarterly results17 Jun · Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On June 17, 2021
May 2021
Apr 2021
26 Apr · Compliance Certificate Obtained By Novartis India Limited ('The Company') From A Practising Company Secretary For The Half Year Ended On March 31, 2021, In Terms Of The Provisions Of Regulations 40(9) & (10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
22 Apr · Compliance Certificate Of Novartis India Limited ('The Company') Under Regulation 7(3) Read With Regulation 7(2) Of The Securities And Exchange Board Of India (LODR) Regulations, 2015 ('SEBI Listing Regulation')
21 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....21 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2021
31 Mar · Board meeting
Meeting on 17 Jun 2021: audited results and final dividend25 Mar · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....25 Mar · Disclosure Under Regulation 30, Schedule III, Part A (13) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')
Feb 2021
11 Feb · Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On Thursday, February 11, 2021
Jan 2021
21 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....20 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2020
31 Dec · Board meeting
Meeting on 11 Feb 2021: quarterly results2 Dec · Detailed Statement Of Cash Flow For The Period Ended September 30, 2020
2 Dec · Disclosure Of Related Party Transactions On A Standalone Basis
Nov 2020
5 Nov · Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On November 5, 2020
Oct 2020
28 Oct · Compliance Certificate Obtained By Novartis India Limited ('The Company') From A Practising Company Secretary For The Half Year Ended On September 30, 2020, In Terms Of The Provisions Of Regulations 40(9) & (10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
27 Oct · Compliance Certificate Of Novartis India Limited ('The Company') Under Regulation 7(3) Read With Regulation 7(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('SEBI Listing Regulation')
21 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....21 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1 1 2 0
Sep 2020
30 Sep · Board meeting
Meeting on 5 Nov 2020: quarterly results
Aug 2020
10 Aug · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....6 Aug · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015